Abstract
Congenital hyperinsulinism (CH) is a major cause of recurrent hypoglycaemia in neonates and infants, results in varying degrees of neurological impairment. Advances in molecular study and imaging technique have been used to guide treatment option for CH. However, there were centres treating CH with long-term medications and reported good neurodevelopmental outcome.
Highlights
Congenital hyperinsulinism (CH) is a major cause of recurrent hypoglycaemia in neonates and infants, results in varying degrees of neurological impairment
Medical data of all patients diagnosed with CH between 15 October 2007 and 31 December 2011 was retrieved from electronic medical record
Three patients were found to have genetic mutation associated with CH
Summary
Congenital hyperinsulinism (CH) is a major cause of recurrent hypoglycaemia in neonates and infants, results in varying degrees of neurological impairment. Advances in molecular study and imaging technique have been used to guide treatment option for CH. There were centres treating CH with long-term medications and reported good neurodevelopmental outcome
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
